Myasthenia Gravis

Zilucoplan’s Edge in Complement Inhibition in Myasthenia Gravis: Miriam Freimer, MD

Understanding How Complement C5 Inhibitors Work in MG: Miriam Freimer, MD

Addressing Myasthenia Gravis Diagnostic Delays and Access Barriers: Marla Black Morgan, MD

Expanding Hope for Pediatric Myasthenia Gravis: Jonathan Strober, MD

Accurate Diagnosis of Myasthenia Gravis in Pediatric Patients Is Challenging: Jonathan Strober, MD

Barriers to Timely Diagnosis of Generalized Myasthenia Gravis: Marla Black Morgan, MD

Pediatric Patients With Myasthenia Gravis Need More Treatment Options: Jonathan Strober, MD

Early Diagnosis Vital to Myasthenia Gravis Treatment: Richard J. Nowak, MD, MS

Delays, Disparities in gMG Diagnosis Among Minority Patients: Marla Black Morgan, MD

52-Week MINT Data Confirm Inebilizumab Benefit in AChR+ gMG: Richard Nowak, MD, MS